Prolonged T-cell response during severe COVID-19 does not contribute to long COVID

FHS
July 10, 2023
1:14 am

Persistent immune activation and elevated cytokine levels were observed in patients with severe COVID-19, even months after recovery. However, the correlation between immune activation and long COVID symptoms appeared to be independent, suggesting other factors influencing disease severity.

Pfizer looking to sell hospital drugs unit — reports

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 13, 2024

Here’s how pharma companies might remove their products from price negotiation

Several of the drugs on the list of 10 that will face price negotiations may not actually end up on the list, thanks to upcoming

August 31, 2023

Can Testosterone Aid Women’s Menopausal Symptoms?

In 2022, Aisha Kabia started to experience symptoms she originally thought could be long COVID: brain fog, fatigue, and joint pain. As an actor based

April 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.